Free Trial

Shore Capital Reiterates "House Stock" Rating for Anpario (LON:ANP)

Anpario logo with Consumer Defensive background

Key Points

  • Investment analysts at Shore Capital have reaffirmed their "house stock" rating for Anpario (LON:ANP).
  • Anpario has a market capitalization of £83.14 million and a significant P/E ratio of 2,009.01.
  • The company engages in producing natural feed additives for animal health, hygiene, and nutrition, with several product brands in its portfolio.
  • MarketBeat previews the top five stocks to own by October 1st.

Anpario (LON:ANP - Get Free Report)'s stock had its "house stock" rating restated by analysts at Shore Capital in a research report issued on Wednesday, Marketbeat reports.

Anpario Trading Down 1.5%

Shares of LON:ANP traded down GBX 7.34 during midday trading on Wednesday, reaching GBX 492.66. The company had a trading volume of 57,874 shares, compared to its average volume of 40,909. The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.16 and a current ratio of 6.15. Anpario has a 1-year low of GBX 286 and a 1-year high of GBX 510. The firm has a market cap of £83.49 million, a price-to-earnings ratio of 2,017.44 and a beta of 0.58. The company has a fifty day simple moving average of GBX 408.39 and a two-hundred day simple moving average of GBX 413.81.

Anpario (LON:ANP - Get Free Report) last released its quarterly earnings results on Wednesday, September 10th. The company reported GBX 16.87 earnings per share for the quarter. Anpario had a return on equity of 8.74% and a net margin of 9.23%. Research analysts predict that Anpario will post 23.5757801 earnings per share for the current year.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Further Reading

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.